Overview

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to decide if controlling stomach acid is related to healing of erosive esophagitis after treatment with esomeprazole magnesium (NEXIUM®) 10 mg and 40 mg once daily.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole